(HCFT) |
| 0 (0%) 10-10 04:02 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 3.98 |
| Resistance 1: | 3.41 |
| Pivot price: | 3.27 |
| Support 1: | 3.21 |
| Support 2: | 3.09 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.292 |
| Book Value | 4.590 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.652 |
| Profit Margin (%) | 40.17 |
| Operating Margin (%) | 38.19 |
| Return on Assets (ttm) | 1.1 |
| Return on Equity (ttm) | 6.4 |
Company news
Mon, 04 Aug 2025
Blue J Announces $122M Series D Financing Led By Oak HC/FT and Sapphire Ventures - Business Wire
Tue, 30 Apr 2024
Trovo Health Announces $15 Million Seed Funding Round Led by Oak HC/FT - Business Wire
Mon, 01 Jan 2024
A metal-phenolic network-assembled nanotrigger evokes lethal ferroptosis via self-supply loop-based cytotoxic reactions - ScienceDirect.com
Tue, 15 Nov 2022
Patricia Kemp, Oak HC/FT Co-Founder & Managing Partner – The Future of Fintech, Crypto Regulation, & Why 2023 Could Bring a Wave of Fintech M&A - Fintech Leaders
Wed, 10 Mar 2021
Advise Health Holdings Announces $100 Million Capital Raise, Led by Oak HC/FT - PR Newswire
Tue, 05 Jan 2021
Novel self-floating tablet for enhanced oral bioavailability of metformin based on cellulose - ScienceDirect.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
